Forward Look

Several targeted drugs were approved in 2020 to treat the most common type of lung cancer.

by Ashley P. Taylor

Survivor Profile

With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.

by Lindsey Konkel

Forward Look

A new way to evaluate patients with prostate cancer.

by Christina Bennett

In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?

by Anna Goshua

After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving.

by Miriam Díaz-Gilbert

African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

by Jon Kelvey

Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

by Anna Goshua

Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.

by Judy Pearson

Stool-based tests could increase access to colorectal cancer screening.

by Jen Tota McGivney

For adolescents and young adults who have been diagnosed with cancer, caregivers can play an influential—but often overlooked—role in providing help and support.

by Carly Flumer